Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 29.05B | 29.29B | 24.84B | 27.45B | 34.24B | 28.89B |
Gross Profit | 14.05B | 14.27B | 11.81B | 16.04B | 16.04B | 11.82B |
EBITDA | 8.52B | 8.58B | 6.79B | 11.71B | 12.71B | 7.89B |
Net Income | 5.31B | 5.01B | 3.75B | 7.03B | 7.60B | 4.30B |
Balance Sheet | ||||||
Total Assets | 197.88B | 222.69B | 203.81B | 189.24B | 200.47B | 184.91B |
Cash, Cash Equivalents and Short-Term Investments | 73.03B | 77.64B | 78.20B | 74.71B | 82.71B | 69.01B |
Total Debt | 50.50B | 76.13B | 50.20B | 48.85B | 48.90B | 50.45B |
Total Liabilities | 66.56B | 88.92B | 72.39B | 58.80B | 73.32B | 62.37B |
Stockholders Equity | 131.32B | 133.77B | 131.41B | 130.44B | 127.15B | 122.54B |
Cash Flow | ||||||
Free Cash Flow | 1.06B | -8.77B | 4.89B | -4.21B | 18.24B | 9.84B |
Operating Cash Flow | 1.06B | -8.46B | 5.09B | -4.11B | 18.35B | 10.74B |
Investing Cash Flow | 0.00 | -15.37B | -179.00M | 2.13B | -2.33B | -884.00M |
Financing Cash Flow | 0.00 | 23.27B | -1.43B | -3.79B | -4.53B | -7.42B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥9.67B | 6.88 | 4.57% | 18.93% | 77.53% | ||
77 Outperform | ¥81.78B | 13.67 | 1.91% | 9.00% | -21.69% | ||
74 Outperform | ¥47.91B | 6.46 | 4.50% | 28.12% | 110.57% | ||
73 Outperform | ¥9.32B | 5.35 | 3.47% | 24.65% | 361.83% | ||
70 Neutral | ¥234.96B | 14.48 | 10.62% | 29.30% | 17.27% | 17.55% | |
63 Neutral | ¥113.08B | 22.01 | 3.73% | 3.61% | 17.91% | 33.58% | |
63 Neutral | €51.32B | 6.05 | 11.09% | 12.14% | 6.12% | -17.70% |